About Oxynext Biotech Private Limited
Data last updated:
Oxynext Biotech Private Limited is a private limited company based in Sanpada, Maharashtra, India, recognised as a startup by DPIIT. It operates in the animal pharmaceuticals and healthcare segment of the pharmaceuticals sector. It was incorporated on 13 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2020PTC347788. Its GSTIN is 27AADCO2878E1ZB (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sachin Nivrutti Auti and Poonam Sachin Auti.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot 1 Flat 1301 Floor 13 Wing A Iraisaa – A Sector – 19 Palm Beach Road, Sanpada, Maharashtra, India – 400705.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.43 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹13.7 Lakh (net margin 4%) and EBITDA of ₹19.53 Lakh (EBITDA margin 5.7%). Revenue has grown at a compounded annual rate (CAGR) of 44% over three years.
For more details, the company can be reached via its website oxygroupindia.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressPlot 1 Flat 1301 Floor 13 Wing A Iraisaa – A Sector – 19 Palm Beach Road, Sanpada, Maharashtra, India – 400705
- IndustryPharma, Animal Pharmaceuticals & Healthcare
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Oxynext Biotech Private Limited
The main business activity of Oxynext Biotech is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Oxynext Biotech Private Limited FY 2025 filings available
Oxynext Biotech Private Limited reported revenue of ₹3.43 Cr (up 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Oxynext Biotech Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 44% over three years, including 35% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Oxynext Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹19.53 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13.7 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Oxynext Biotech Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Oxynext Biotech are in the company report.
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Oxynext Biotech Private Limited
Oxynext Biotech Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Animal Pharma). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vetenza Animal Healthcare Private Limited | ₹3.8 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Poly Care Labs (Gujarat) Private Limited | ₹3.79 Cr (FY 2025) | •••• | •••• | -13.0% | •••• | Vadodara, Gujarat, India |
| Intracare Sea Private Limited | ₹3.66 Cr (FY 2025) | •••• | •••• | •••• | Karnal, Haryana, India | |
| Bovisol Animal Health Care Private Limited | ₹3.65 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Satara, Maharashtra, India |
| Nexell Laboratories Private Limited | ₹3.61 Cr (FY 2023) | •••• | •••• | 5.0% | •••• | Hyderabad, Telangana, India |
| Oxynext Biotech Private Limited this company | ₹3.43 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Sanpada, Maharashtra, India |
| Cheerans Lab Pvt Ltd | ₹3.31 Cr (FY 2024) | •••• | •••• | -13.0% | •••• | Thrissur, Kerala, India |
| Vyara Vaibhav Cattlefeed Private Limited | ₹3.22 Cr (FY 2025) | •••• | •••• | 715.0% | •••• | Songadh, Gujarat, India |
| Bio Care India Private Limited | ₹3.22 Cr (FY 2023) | •••• | •••• | -83.0% | •••• | Nagpur, Maharashtra, India |
| Vet Origin Private Limited | ₹3.13 Cr (FY 2025) | •••• | •••• | 378.0% | •••• | Thiruvananthapuram, Kerala, India |
| Indo Safe Pharma Private Limited | ₹3.12 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Oxynext Biotech by revenue in the Pharma industry (Animal Pharma), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Oxynext Biotech Private Limited
Oxynext Biotech Private Limited is audited by ShettyandShetty for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| ShettyandShetty | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Oxynext Biotech Private Limited
Oxynext Biotech has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Nivrutti Auti Also directs: Wegrow Business Facilitators LLP | Director | 13 Oct 2020 | 5 Years 11 Months | Current |
| Poonam Sachin Auti | Director | 13 Oct 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Oxynext Biotech Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Oxynext Biotech Private Limited
Oxynext Biotech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Oxynext Biotech Private Limited
Oxynext Biotech Private Limited has a workforce of 0 employees as of Apr 07, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Oxynext Biotech Private Limited
Oxynext Biotech Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Poonam Sachin Auti was appointed as Director on 13 Oct 2020.
Credit Ratings, Litigation & Regulatory Alerts for Oxynext Biotech Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Oxynext Biotech Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Oxynext Biotech Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Oxynext Biotech Private Limited
Oxynext Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AADCO2878E1ZB | Maharashtra | Active | 06 Aug 2021 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Oxynext Biotech Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Oxynext Biotech Private Limited
Oxynext Biotech is an active private limited company based in Sanpada, Maharashtra, India. The company works in animal pharmaceuticals and healthcare, within the pharma industry. It was incorporated on 13 October 2020 (6+ years old) and is registered under CIN U24100MH2020PTC347788.
Oxynext Biotech reported revenue of ₹3.43 Cr for FY 2025 (up 35% YoY).
Oxynext Biotech has 2 current directors:
- Sachin Nivrutti Auti - Director
- Poonam Sachin Auti - Director
Oxynext Biotech reported a net profit of ₹13.7 Lakh (net margin 4%) and EBITDA of ₹19.53 Lakh (EBITDA margin 5.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Oxynext Biotech is 44% over three years. In the latest year (FY 2025) revenue rose 35%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Oxynext Biotech is 27AADCO2878E1ZB, registered in Maharashtra.
The CIN (Corporate Identification Number) of Oxynext Biotech is U24100MH2020PTC347788. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Oxynext Biotech was incorporated on 13 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Oxynext Biotech by revenue are Vetenza Animal Healthcare Private Limited, Poly Care Labs (Gujarat) Private Limited, Intracare Sea Private Limited, Bovisol Animal Health Care Private Limited, Nexell Laboratories Private Limited and 5 more, all in the Pharma industry (Animal Pharma).
Poonam Sachin Auti was appointed as Director on 13 Oct 2020. Sachin Nivrutti Auti was appointed as Director on 13 Oct 2020.
Yes, Oxynext Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).